For the Inventor, By the Inventor

Enter assignee name

Regensburg, Germany

Gerresheimer Regensburg Gmbh

Calculating rank

USPTO Granted Patents = 58

% Expired Patents = 1.7

EPO Patents = 51

Forward Citations = 178

Loading Chart...

Loading Chart...

51 inventors (with patents filed for the assignee):

Udo Leuschner (10 out of 24 patents)

Maximilian Vogl (9 out of 10 patents)

Vojan Vaclav (7 out of 7 patents)

4. Juergen Pfrang (5 out of 10 patents)

5. Andreas Fraas (5 out of 10 patents)

6. Julia Volkmuth (5 out of 5 patents)

7. Jörg Großer (5 out of 5 patents)

8. Frank Wittland (4 out of 10 patents)

9. Michael Strehl (4 out of 17 patents)

10. Richard Kiener (4 out of 4 patents)

11. Michael Wiglenda (3 out of 3 patents)

12. Andreas Eder (3 out of 3 patents)

13. Marion Butz (3 out of 4 patents)

14. Florian Reger (3 out of 3 patents)

15. Vladislav Löpp (3 out of 3 patents)

Core Competencies:

Glass Container

Syringe Production

Injection Molding

Safety Device

Lancing Device

Pharmaceutical Administration

Molding Process

Surface Structure

58 patents: Sort by Forward Citations

1. 12558702 - Manufacturing containers (2026-02-24),

2. 12071362 - Method and system for producing a glass container, and air bearing (2024-08-27),

3. 11851359 - Device for reshaping a glass product (2023-12-26),

4. 11850778 - Method for producing a syringe with an integrated closure element (2023-12-26),

5. 11835397 - Dummy for monitoring the molding process (2023-12-05),

6. 11833315 - Additional function of a safety device for injection devices (2023-12-05),

7. 11827554 - Method and system for producing glassware (2023-11-28),

8. 11807484 - Cover member for a storing means for stacked flat elements (2023-11-07),

9. 11745205 - Manufacturing containers (2023-09-05),

10. 11667064 - Method for producing a hollow injection-moulded part (2023-06-06),

11. 11565479 - Method for connecting a first component to a second component (2023-01-31),

12. 11491284 - Plasma treatment method for coating a glass syringe body for a hypodermic pre-filled glass syringe (2022-11-08),

13. 11458658 - Method for manufacturing an injection device with a bypass channel and tool for this purpose (2022-10-04),

14. 11351311 - Glass syringe-side assembly aid element, method for fastening a glass syringe-side assembly aid element and method for producing a glass syringe-side assembly aid element, as well as an arrangement consisting of a glass syringe and an assembly aid element (2022-06-07),

15. 11008243 - Method for producing a syringe having a piercing means (2021-05-18),

Company Overview

Gerresheimer Regensburg GmbH specializes in the manufacturing of medical devices, focusing on innovative solutions for pharmaceutical administration. The company is renowned for its expertise in producing glass containers and syringes, employing advanced injection molding techniques. Their product range includes safety devices and lancing devices, designed to enhance patient safety and ease of use. Located in Regensburg, Germany, Gerresheimer is committed to advancing healthcare through high-quality, reliable medical products.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

58 Patents

#7 in Regensburg

#947 in Germany

#12,415 in the World

Regensburg, Germany

Gerresheimer Regensburg Gmbh

Forward Citations = 178

51 inventors:

Udo Leuschner (10 out of 24 patents)

Maximilian Vogl (9 out of 10 patents)

Vojan Vaclav (7 out of 7 patents)

4. Juergen Pfrang (5 out of 10 patents)

5. Andreas Fraas (5 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gerresheimer Regensburg Gmbh. Retrieved from https://idiyas.com/company/gerresheimer-regensburg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…